Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights
Toronto, Ontario--(Newsfile Corp. - December 15, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a...
Day: December 15, 2021
Innovaccer Raises $150 Million Series E Round at $3.2 Billion Valuation, Continues Rapid Growth Trajectory
The Innovaccer Health Cloud achieves swift adoption as healthcare’s new platform for accelerating digital transformation Company announces new Innovation Accelerators...
NextGen Healthcare Announces Retirement of Chief Medical Officer Betty Rabinowitz and Promotion of Robert Murry to Chief Medical Officer
ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced the retirement of its...
Inogen Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
Cannabis Suisse Corp. to Proceed with the Development of the IT Product “Cannabis Life”
DIETIKON, SWITZERLAND / ACCESSWIRE / December 15, 2021 / Cannabis Suisse Corp. (OTC PINK:CSUI), registered in Nevada, announced their development...
XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / December 15, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...
Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin
Ad hoc announcement pursuant to Art. 53 LRALLSCHWIL, SWITZERLAND / ACCESSWIRE / December 15, 2021 / Polyphor AG (SIX:POLN) and...
Relief Reports that U.S. Collaboration Partner Announces New, Favorable Safety Report for Aviptadil in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19
GENEVA, SWITZERLAND / ACCESSWIRE / December 15, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQBRLFTY) (" Relief "), a biopharmaceutical company...